Generation of cellular therapies for the treatment or prevention of relapse following allogeneic stem cell transplantation. CAR, chimeric antigen receptor; CIK, cytokine-induced killer; CTL, cytotoxic T lymphocyte; DLI, donor lymphocyte infusion; MIL, marrow-infiltrating lymphocyte; NK, natural killer; TIL, tumor-infiltrating lymphocyte.